In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb looks back at ADA 2023 highlights and her interviews with diabetes company execs. Reed Miller discusses his Cardio Conversation with Volta Medical and Hannah Daniel discusses the FDA’s Clinical Decision Support Software final guidance.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

Diabetes, ADA 2023

Better Therapeutics Plans Diabetes PDT Launch Following FDA De Novo Authorization

Exec Chat: Tandem CEO Sheridan On Coming Mobi Pump, New Algorithms, And Taking Share From Medtronic

‘Closest To What The Pancreas Would Actually Do’: Medtronic Diabetes Execs On Marketing Plans for MiniMed 780G

Exec Chat: Dexcom’s CEO On Meeting New CGM Markets While Scoping Consumer Opportunities

AI, Regulatory Watch

Cardio Conversations: 'Trials, Trials, Trials!' Volta Has Big Ambitions For AI In EP

What Changes To The AI Act Would Benefit Medtech Most?

CDS Final Guidance Infringes On Free Speech, Professor Says